• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肝病患者心血管异常的评估:一项横断面研究。

The Assessment of Cardiovascular Abnormalities in Patients With Chronic Liver Disease: A Cross-Sectional Study.

作者信息

Shah Kunjan PareshKumar, Kuruvada Sailaja, Gopalakrishnan Mridulkrishnan, Latchireddy Bhargavi, Prathima Talla, Patra Niyati

机构信息

Department of General Medicine, Dr. N.D. Desai Faculty of Medical Science and Research, Nadiad, IND.

Department of General Medicine, University College London, London, GBR.

出版信息

Cureus. 2024 Nov 9;16(11):e73311. doi: 10.7759/cureus.73311. eCollection 2024 Nov.

DOI:10.7759/cureus.73311
PMID:39655150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11626255/
Abstract

Background Chronic liver disease (CLD) is associated with a wide range of systemic complications, including cardiovascular abnormalities. This study aimed to assess the prevalence of cardiac abnormalities and to correlate with the severity of liver disorder. Materials and methods A cross-sectional analysis comprising 120 adult subjects diagnosed with CLD was performed. Data were collected through clinical assessments, including liver function tests, echocardiography, and electrocardiograms (ECG). The severity of CLD was determined using the Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scoring systems. Results In this study, 85 (70.8%) were men, and the major cause of CLD was alcoholism in 89 (66.7%) of the patients. Regarding CLD severity, the majority of patients were in MELD stage 2, and 70 (58.3%) and 76 (63.3%) were in CTP class C. The prevalence of various cardiac abnormalities was as follows: left ventricular systolic dysfunction (LVSD) in 25 (20.8%), left ventricular diastolic dysfunction (LVDD) in 76 (63.3%), and prolonged corrected QT (QTc) in 52 (43.3%) of the CLD patients. The values of the QTc interval were higher in MELD stage 3, and it was significant (p=0.001). The association between LVSD (p=0.004) and LVDD (p=0.001) was significant, and the proportion of CLD subjects with cardiac dysfunction was greater in CTP class C compared to classes B and A. Conclusion The present study highlights a concerning prevalence of cardiovascular abnormalities among chronic liver disease patients, underscoring the need for routine cardiovascular assessment in this population.

摘要

背景 慢性肝病(CLD)与多种全身并发症相关,包括心血管异常。本研究旨在评估心脏异常的患病率,并与肝脏疾病的严重程度相关联。材料与方法 对120名被诊断为CLD的成年受试者进行了横断面分析。通过临床评估收集数据,包括肝功能检查、超声心动图和心电图(ECG)。使用Child-Turcotte-Pugh(CTP)和终末期肝病模型(MELD)评分系统确定CLD的严重程度。结果 在本研究中,85名(70.8%)为男性,CLD的主要病因是酗酒,89名(66.7%)患者如此。关于CLD严重程度,大多数患者处于MELD 2期,70名(58.3%)和76名(63.3%)处于CTP C级。各种心脏异常的患病率如下:25名(20.8%)CLD患者存在左心室收缩功能障碍(LVSD),76名(63.3%)存在左心室舒张功能障碍(LVDD),52名(43.3%)存在校正QT(QTc)延长。QTc间期值在MELD 3期更高,且具有显著性(p = 0.001)。LVSD(p = 0.004)和LVDD(p = 0.001)之间的关联具有显著性,与B级和A级相比,CTP C级CLD受试者中心脏功能障碍的比例更高。结论 本研究突出了慢性肝病患者中心血管异常令人担忧的患病率,强调了对该人群进行常规心血管评估的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dd/11626255/9e65efe99b9d/cureus-0016-00000073311-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dd/11626255/9e65efe99b9d/cureus-0016-00000073311-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dd/11626255/9e65efe99b9d/cureus-0016-00000073311-i01.jpg

相似文献

1
The Assessment of Cardiovascular Abnormalities in Patients With Chronic Liver Disease: A Cross-Sectional Study.慢性肝病患者心血管异常的评估:一项横断面研究。
Cureus. 2024 Nov 9;16(11):e73311. doi: 10.7759/cureus.73311. eCollection 2024 Nov.
2
Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study.非B型和非C型肝炎与乙型和丙型肝炎相关慢性肝病的严重程度:一项回顾性、观察性、比较研究。
Cureus. 2020 Dec 26;12(12):e12294. doi: 10.7759/cureus.12294.
3
Correlation of Serum Prolactin Levels With Chronic Liver Disease Severity in a Tertiary Care Hospital in Eastern India.印度东部一家三级护理医院血清催乳素水平与慢性肝病严重程度的相关性
Cureus. 2025 Jan 8;17(1):e77164. doi: 10.7759/cureus.77164. eCollection 2025 Jan.
4
Evaluation of subclinical left ventricular systolic dysfunction using two-dimensional speckle-tracking echocardiography in patients with Child-Pugh A and B cirrhosis: A case-control study.应用二维斑点追踪超声心动图评价 Child-Pugh A、B 级肝硬化患者亚临床左心室收缩功能障碍:病例对照研究。
Indian J Gastroenterol. 2022 Dec;41(6):567-575. doi: 10.1007/s12664-022-01277-w. Epub 2022 Dec 28.
5
Liver cirrhosis and left ventricle diastolic dysfunction: Systematic review.肝硬化与左心室舒张功能障碍:系统评价。
World J Gastroenterol. 2019 Aug 28;25(32):4779-4795. doi: 10.3748/wjg.v25.i32.4779.
6
Living Donor Liver Transplantation in a Cohort of Recipients With Left Ventricular Systolic Dysfunction.左心室收缩功能障碍受者队列中的活体肝移植
J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1040-1047. doi: 10.1016/j.jceh.2022.03.001. Epub 2022 Mar 16.
7
Diagnosis and Management of Cirrhotic Cardiomyopathy.肝硬化性心肌病的诊断与管理
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):186-199. doi: 10.1016/j.jceh.2021.08.016. Epub 2021 Aug 21.
8
Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?肝硬化性心肌病与肝硬化严重程度有关吗?
Rambam Maimonides Med J. 2023 Jan 29;14(1):e0001. doi: 10.5041/RMMJ.10488.
9
Corrected QT interval in cirrhosis: A systematic review and meta-analysis.肝硬化患者的校正QT间期:一项系统评价与荟萃分析。
World J Hepatol. 2023 Sep 27;15(9):1060-1083. doi: 10.4254/wjh.v15.i9.1060.
10
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.预测广泛肝病患者的死亡率——对终末期肝病模型(MELD)、Child-Turcotte-Pugh(CTP)评分以及肌酐修正CTP评分的评估
J Clin Exp Hepatol. 2011 Dec;1(3):161-8. doi: 10.1016/S0973-6883(11)60233-8. Epub 2012 Jan 2.

本文引用的文献

1
Evaluating Diastolic Dysfunction as an Indicator of Cirrhotic Cardiomyopathy in Decompensated Chronic Liver Disease.评估舒张功能障碍作为失代偿期慢性肝病中肝硬化心肌病指标的作用
Cureus. 2024 Jun 28;16(6):e63388. doi: 10.7759/cureus.63388. eCollection 2024 Jun.
2
Etiological Spectrum of Cirrhosis in India: A Systematic Review and Meta-analysis.印度肝硬化的病因谱:一项系统评价与荟萃分析
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101291. doi: 10.1016/j.jceh.2023.10.002. Epub 2023 Oct 9.
3
Cirrhotic cardiomyopathy: Pathogenesis, clinical features, diagnosis, treatment and prognosis.
肝硬化性心肌病:发病机制、临床特征、诊断、治疗和预后。
Rev Port Cardiol. 2024 Apr;43(4):203-212. doi: 10.1016/j.repc.2023.07.010. Epub 2023 Dec 22.
4
A case-cohort study of left ventricular diastolic dysfunction in patients with cirrhosis: the liver-heart axis.肝硬化患者左心室舒张功能障碍的病例队列研究:肝-心轴
Ann Gastroenterol. 2023 Nov-Dec;36(6):678-685. doi: 10.20524/aog.2023.0837. Epub 2023 Oct 30.
5
A public health perspective on mitigating the global burden of chronic liver disease.从公共卫生角度减轻全球慢性肝病负担。
Hepatology. 2024 Feb 1;79(2):451-459. doi: 10.1097/HEP.0000000000000679. Epub 2023 Nov 9.
6
Global burden of liver disease: 2023 update.全球肝病负担:2023 年更新。
J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27.
7
Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist.从心内科医生的临床实用角度看心血管疾病与肝脏疾病的关联。
Nutrients. 2023 Feb 1;15(3):748. doi: 10.3390/nu15030748.
8
Diagnosis and Management of Cirrhotic Cardiomyopathy.肝硬化性心肌病的诊断与管理
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):186-199. doi: 10.1016/j.jceh.2021.08.016. Epub 2021 Aug 21.
9
Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure.射血分数保留的心力衰竭患者肝脏硬度与舒张功能、左心室肥厚及右心功能的相关性
Front Cardiovasc Med. 2021 Nov 25;8:748173. doi: 10.3389/fcvm.2021.748173. eCollection 2021.
10
Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis.舒张功能障碍是失代偿期肝硬化患者生存预后不良的一个预测指标。
Int J Hepatol. 2021 Dec 2;2021:5592376. doi: 10.1155/2021/5592376. eCollection 2021.